Acer Medical Inc.

Taipei Exchange:6857.TWO

Sector

🏥 Health Care

Industries

🤖 Artificial Intelligence (AI)

📊 Big Data

🔬 Clinical Trials

🏥 Hospitals & Clinics

💻 Telehealth

Location

Taiwan

Market Cap

USD 62.20 M

Share Price

USD 4.09

Avg Daily Volume

3,093

Change (1 day)

0.17%

Change (1 year)

-20.56%

Change (YTD)

-5.68%

Acer Medical Inc. Revenue for the year ending December 31, 2024: USD 1.53 M

Acer Medical Inc. Revenue is USD 1.53 M for the year ending December 31, 2024, a 70.84% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Acer Medical Inc. Revenue for the year ending December 31, 2023 was USD 894.09 K, a 109.87% change year over year.
Acer Medical Inc. Revenue for the year ending December 31, 2022 was USD 426.03 K, a 22.67% change year over year.
Acer Medical Inc. Revenue for the year ending December 31, 2021 was USD 347.28 K, a 863.35% change year over year.
Acer Medical Inc. Revenue for the year ending December 31, 2020 was USD 36.05 K.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

Taipei Exchange: 6857.TWO

Acer Medical Inc.

CEO	Mr. Yin Xiong Xu
IPO Date	March 4, 2022
Location	Taiwan
Headquarters	No. 88, Section 1, Xintai 5th Road
Employees	22
Sector	🏥 Health Care
Industries Artificial Intelligence (AI) 📊 Big Data 🔬 Clinical Trials 🏥 Hospitals & Clinics 💻 Telehealth

Description

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.